1. Home
  2. LSCC vs NBIX Comparison

LSCC vs NBIX Comparison

Compare LSCC & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

N/A

Current Price

$100.56

Market Cap

11.8B

Sector

Technology

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$131.38

Market Cap

13.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LSCC
NBIX
Founded
1983
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.8B
13.9B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
LSCC
NBIX
Price
$100.56
$131.38
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
22
Target Price
$102.08
$175.23
AVG Volume (30 Days)
2.2M
1.2M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
41.95
EPS
0.02
4.67
Revenue
$385,961,000.00
$161,626,000.00
Revenue This Year
$34.94
$22.57
Revenue Next Year
$19.93
$9.56
P/E Ratio
$5,053.50
$28.00
Revenue Growth
N/A
977.51
52 Week Low
$34.69
$84.23
52 Week High
$108.08
$160.18

Technical Indicators

Market Signals
Indicator
LSCC
NBIX
Relative Strength Index (RSI) 63.99 43.60
Support Level $92.88 $122.82
Resistance Level $108.08 $137.37
Average True Range (ATR) 4.64 3.88
MACD 0.24 0.04
Stochastic Oscillator 66.75 38.02

Price Performance

Historical Comparison
LSCC
NBIX

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Share on Social Networks: